Clinical Trial Update: Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Induced-T Cell Like NK cellular immunotherapy for cancers lacking MHC-I, currently recruiting. The therapy uses engineered…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Induced-T Cell Like NK Cellular Immunotherapy

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Anti-cancer Cell Immunotherapy, T Cell and NK Cell | Phase 1, Phase 2 | Status: RECRUITING